An Immunotherapy Option for Treating Kidney Cancer
The FDA has approved an immunotherapy known as immune checkpoint inhibition for the treatment of certain patients with kidney...
Progress Against Cancer
The FDA has approved an immunotherapy known as immune checkpoint inhibition for the treatment of certain patients with kidney...
THE FDA GRANTED ACCELERATED APPROVAL TO A TARGETED THERAPY FOR PATIENTS WITH CML RESISTANT TO OTHER THERAPEUTICS The U.S....
THE FDA APPROVED THE FIRST ADJUVANT IMMUNOTHERAPY FOR EARLY LUNG CANCER The U.S. Food and Drug Administration (FDA) granted...
THE FDA APPROVED THE IMMUNE CHECKPOINT INHIBITOR PEMBROLIZUMAB IN COMBINATION AND AS A SINGLE AGENT FOR ADVANCED CERVICAL CANCER...
THE FDA APPROVED A NEW TYPE OF CANCER INHIBITOR FOR CERTAIN PATIENTS WITH A HIGH RISK OF RECURRENCE The...
THE FDA APPROVED THE FIRST CAR-T CELL THERAPY FOR CERTAIN PATIENTS WITH this aggressive form of LEUKEMIA The U.S....
THE FDA GRANTED ACCELERATED APPROVAL TO A NEW THERAPY FOR ADVANCED CERVICAL CANCER The U.S. Food and Drug Administration...
The FDA approved a tyrosine kinase inhibitor for certain patients with thyroid cancer. The U.S. Food and Drug Administration...
The FDA granted accelerated approval to a new targeted therapeutic and companion diagnostic test for certain adult patients with...
THE FDA GRANTED ACCELERATED APPROVAL TO ZANUBRUTINIB FOR CERTAIN ADULTS WITH MARGINAL ZONE LYMPHOMA The U.S. Food and Drug...